Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.79)
# 2,956
Out of 4,789 analysts
177
Total ratings
42.25%
Success rate
-3.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVRO Nevro | Downgrades: Underweight | $9 → $4 | $5.84 | -31.51% | 9 | Dec 2, 2024 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $495.27 | +31.24% | 13 | Dec 2, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $2.40 | +108.33% | 15 | Nov 11, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $12.75 | -5.88% | 12 | Jul 15, 2024 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $135 → $130 | $104.68 | +24.19% | 15 | Jul 15, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $130 → $120 | $113.18 | +6.03% | 11 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $67.28 | +41.20% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $89.86 | +9.06% | 9 | Nov 22, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $94.93 | -10.46% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $24.58 | -38.97% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $325 → $343 | $262.61 | +30.61% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $6.73 | +108.02% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $34.23 | +40.23% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $72.48 | +40.73% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $100.88 | -42.51% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $14.50 | +37.93% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $68.29 | +91.83% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $132.65 | +0.26% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $372.25 | -40.90% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $138.19 | +173.54% | 2 | Feb 25, 2022 |
Nevro
Dec 2, 2024
Downgrades: Underweight
Price Target: $9 → $4
Current: $5.84
Upside: -31.51%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $495.27
Upside: +31.24%
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.40
Upside: +108.33%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $12.75
Upside: -5.88%
iRhythm Technologies
Jul 15, 2024
Maintains: Overweight
Price Target: $135 → $130
Current: $104.68
Upside: +24.19%
Zimmer Biomet Holdings
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $130 → $120
Current: $113.18
Upside: +6.03%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $67.28
Upside: +41.20%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $89.86
Upside: +9.06%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $94.93
Upside: -10.46%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $24.58
Upside: -38.97%
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $262.61
Upside: +30.61%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $6.73
Upside: +108.02%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $34.23
Upside: +40.23%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $72.48
Upside: +40.73%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $100.88
Upside: -42.51%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $14.50
Upside: +37.93%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $68.29
Upside: +91.83%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $132.65
Upside: +0.26%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $372.25
Upside: -40.90%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $138.19
Upside: +173.54%